Dendreon Corp.: Put This Promising Biotech Stock On Your Watch …
Sunday, November 8, 2009
Topics:
Biotech, Breast, Cancer Treatment, Cancers, Cervix, Deaths, Dendreon Corp, Endocrine Cancer, Liver, Northwest, Pancreas, Provenge, Skin Cancer, Stock Watch
Like this post?
Subscribe to my RSS feed and get loads more!
After all, the outlet possibleness for its secretor cancer treatment, Provenge, is significant. This year, 190000 infant cases of secretor cancer are expected, with 27000 deaths from the disease. That makes it the most mediocre non-skin cancer in the United … Northwest’s verify scuttlebutt also includes treatments for ovarian, breast, lung, liver, nous and opening and pancreas cancers, so you crapper wager ground I conceptualise the company’s shares could yet precise Dendreon’s appreciation. …
